Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Esther Natalie Oliva, Francesco Albano, Nicola Di Renzo, Vincenzo Pavone, Stefano Molica, Fortunato Morabito, Attilio Guarini, Giuseppe Tarantini, Silvana Capalbo, MD, Emilio Iannitto, Giovanni Quarta, MD, Nicola Cascavilla, Pierfrancesco Tassone, MD, Francesco Iuliano, Roberto Porciello, Paola Casieri, Carmelo Laganà, Francesco Nobile, Giorgina Specchia

Blood (2012) 120 (21): 50623.

https://doi.org/10.1182/blood.V120.21.50623.50623

Published: 2012

Journal Articles

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Blood (2012) 120 (21): 5200.

https://doi.org/10.1182/blood.V120.21.5200.5200

Published: 2012

Journal Articles

Increases In Mirna-145 and Mirna-146a Expression In Patients with IPSS Lower-Risk Myelodysplastic Syndromes and Del(5q) Treated with Lenalidomide.

Esther Natalie Oliva, MD, Francesco Nobile, MD, Pasquale Iacopino, MD, Giuliana Alimena, MD, Francesco Di Raimondo, Giuseppe A Palumbo, MD, Carmelo Laganà, Maria Grazia D'Errigo, BSc, Roberto Latagliata, MD, Maria Cuzzola, BSc

Blood (2010) 116 (21): 3631.

https://doi.org/10.1182/blood.V116.21.3631.3631

Published: 2010

Journal Articles

Primary Immune Thrombocytopenia (ITP) Guidelines for Bone Marrow Aspirate Reduce the Diagnostic Rate of Myelodysplastic Syndromes

Iolanda Vincelli, MD, Esther Natalie Oliva, MD, Francesca Ronco, PhD, Patrizia Cufari, PhD, Bianca Oliva, PhD, Valentina Gatto, PhD, Carmelo Laganà, PhD, Maria Grazia D'Errigo, Francesco Nobile, MD

Blood (2010) 116 (21): 4974.

https://doi.org/10.1182/blood.V116.21.4974.4974

Published: 2010

Journal Articles

Gene Expression Changes in Bone Marrow of MDS Patients with Del(5q) During Lenalidomide Treatment.

Esther Natalie Oliva, MD, Maria Cuzzola, Roberto Latagliata, MD, Francesca Ronco, MD, D'Errigo Maria Grazia, Morabito Fortunato, MD, Galimberti Sara, MD, Enrico Balleari, MD, Giorgina Specchia, MD, Agostino Cortelezzi, MD, Antonella Poloni, MD, Carlo Finelli, MD, Giuliana Alimena, Pasquale Iacopino, MD, Carmelo Laganà, MD, Francesco Mendicino, MD, Filippo Rodà, MD, Francesco Nobile, MD

Blood (2009) 114 (22): 2622.

https://doi.org/10.1182/blood.V114.22.2622.2622

Published: 2009

Journal Articles

JAK2 (V617F) Mutation Levels and Marrow Fibrosis in Patients Affected by Budd-Chiari Syndrome and Non-Cirrhotic Extra-Hepatic Portal Vein Obstruction.

Angela Rago, MD, Chiara Marzano, MD, Corrado Mammì, MD, Carmelo Laganà, MD, Angelo Fama, MD, Luisa Bizzoni, MD, Gabriella Tomei, MD, Stefania Trasarti, MD, Francesca Gioisa, MD, Massimo Breccia, MD, Ida Carmosino, MD, Roberto Latagliata, MD, Giuliana Alimena, MD, Robert Foa, MD, Oliviero Riggio, MD, Agostino Tafuri, MD

Blood (2007) 110 (11): 4652.

https://doi.org/10.1182/blood.V110.11.4652.4652

Published: 2007

NARROW

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Increases In Mirna-145 and Mirna-146a Expression In Patients with IPSS Lower-Risk Myelodysplastic Syndromes and Del(5q) Treated with Lenalidomide.

Primary Immune Thrombocytopenia (ITP) Guidelines for Bone Marrow Aspirate Reduce the Diagnostic Rate of Myelodysplastic Syndromes

Gene Expression Changes in Bone Marrow of MDS Patients with Del(5q) During Lenalidomide Treatment.

JAK2 (V617F) Mutation Levels and Marrow Fibrosis in Patients Affected by Budd-Chiari Syndrome and Non-Cirrhotic Extra-Hepatic Portal Vein Obstruction.

Email alerts

ASH Publications

American Society of Hematology

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Increases In Mirna-145 and Mirna-146a Expression In Patients with IPSS Lower-Risk Myelodysplastic Syndromes and Del(5q) Treated with Lenalidomide.

Primary Immune Thrombocytopenia (ITP) Guidelines for Bone Marrow Aspirate Reduce the Diagnostic Rate of Myelodysplastic Syndromes

Gene Expression Changes in Bone Marrow of MDS Patients with Del(5q) During Lenalidomide Treatment.

JAK2 (V617F) Mutation Levels and Marrow Fibrosis in Patients Affected by Budd-Chiari Syndrome and Non-Cirrhotic Extra-Hepatic Portal Vein Obstruction.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only